Showing results (121-130 of 171) with videos related to
Sort By:
Pageof 18
Cytotherapy|November 12, 2009
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responsesYun Lin, Humilidad F Gallardo, Geoffrey Y Ku, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction CancersPeter C Enzinger, Barbara Ann Burtness, Donna Niedzwiecki, et al.Annals of Surgery|November 20, 2020
Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?Smita Sihag, Tamar Nobel, Meier Hsu, et al.Future Oncology (London, England)|May 26, 2022
PD-L1 expression and overall survival in Asian and western patients with gastric cancerSun Young Rha, Geoffrey Y Ku, Hyo Song Kim, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 8, 2022
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)Kohei Shitara, Toshihiko Doi, Hisashi Hosaka, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 4, 2024
Patient metabolic profile defined by liver and muscle 18F-FDG PET avidity is independently associated with overall survival in gastric cancerGerardo A Vitiello, Vetri Sudar Jayaprakasam, Laura H Tang, et al.International Journal of Radiation Oncology, Biology, Physics|June 10, 2026
NRG-GI007: Phase I study of OBP-301, an oncolytic virus, and definitive chemoradiation in locally advanced esophageal cancerGeoffrey Y Ku, Kathryn Winter, David Ilson, et al.The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinomaArianna Barbetta, Meier Hsu, Kay See Tan, et al.Annals of Surgical Oncology|June 10, 2026
Long-Term Outcomes of Patients with Gastric Cancer and Positive Peritoneal CytologyCary Jo R Schlick, Ryan J Ellis, Johan L Dikken, et al.Cancer Discovery|November 23, 2018
EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric CancerFrancisco Sanchez-Vega, Jaclyn F Hechtman, Pau Castel, et al.Pageof 18